UK Markets open in 5 hrs 35 mins

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.62+0.53 (+8.70%)
At close: 04:00PM EST
6.74 +0.12 (+1.81%)
After hours: 07:52PM EST
Full screen
Trade prices are not sourced from all markets
Previous close6.09
Bid6.60 x 2900
Ask6.62 x 1300
Day's range5.88 - 6.66
52-week range3.07 - 23.42
Avg. volume5,162,462
Market cap1.957B
Beta (5Y monthly)1.44
PE ratio (TTM)N/A
EPS (TTM)-2.53
Earnings date28 Feb 2022 - 04 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est22.83
  • Motley Fool

    Here's Why Amyris Stock Plunged 54% in November

    The days grew shorter last month, as did investors' patience with this synthetic-biology specialist.

  • Motley Fool

    Why Shares of Amyris Are Plummeting This Week

    Consistent with the falling temperatures outside, investors are turning a cold shoulder to synthetic biology specialist Amyris (NASDAQ: AMRS) this week. As of the close of the trading session on Thursday, shares of Amyris have plunged 47% from their closing price of $14.09 last Friday. Beginning the week on an inauspicious note, Amyris reported third-quarter 2021 earnings after the market closed on Monday.

  • Motley Fool

    Why Shares of Amyris Are Getting Crushed Today

    Failing to deliver on both the top and bottom lines, synthetic-biology specialist Amyris (NASDAQ: AMRS) reported disappointing third-quarter 2021 earnings results yesterday after the market closed. In addition, investors are selling shares after learning that the company is raising capital through the issuance of senior convertible notes. Although the company reported a year-over-year sales increase of 39.7%, it didn't seem to be enough to satisfy investors' appetites.